Vaccine or monoclonal therapy: which is the winning weapon against COVID-19?

Lo Muzio, Lorenzo; Bizzoca, Maria Eleonora

Lo Muzio, Lorenzo; Bizzoca, Maria Eleonora.

Lo Muzio L; Department of Clinical and Experimental Medicine, University of Foggia, Foggia, Italy; Istituto Superiore di Sanità, Rome, Italy; CI.N.B.O. (Consorzio Interuniversitario per la Bio-Oncologia), Chieti, Italy. Electronic address: lorenzo.lomuzio@unifg.it.
Bizzoca ME; Department of Clinical and Experimental Medicine, University of Foggia, Foggia, Italy.

J Glob Antimicrob Resist ; 26: 202-204, 2021 09.

Article in English | MEDLINE | ID: covidwho-1300881

Subject(s)

COVID-19; Vaccines; Humans; SARS-CoV-2

Keywords

COVID-19; Coronavirus; Monoclonal antibodies; Reinfection; SARS-CoV-2; Vaccine

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Vaccines / COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: J Glob Antimicrob Resist Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google